Document Detail


Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
MedLine Citation:
PMID:  6724013     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twelve women with pelvic endometriosis were treated with 600 mg of danazol daily for 24 weeks. The molar and fractional lecithin:cholesterol acyl transfer (LCAT) rates and the concentrations of cholesterol, phospholipids, and triglycerides were determined in plasma and in the very low-density lipoprotein, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and HDL2 and HDL3 fractions before, during, and after the medication. After 2 weeks the HDL, HDL2, and HDL3 cholesterol concentrations were reduced by 49%, 73%, and 29%, respectively, while the LDL level was increased by 14%. The molar and fractional LCAT rates decreased during treatment, and these reduced LCAT rates are consistent with a reduced fractional LDL removal. Within 8 weeks after cessation of medication, all parameters had returned to the pretreatment levels.
Authors:
L Fåhraeus; U Larsson-Cohn; S Ljungberg; L Wallentin
Related Documents :
3096633 - Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
6520723 - Serum lipid and lipoprotein concentrations following exposure to ozone.
11238783 - The role of fat depletion in the biological benefits of caloric restriction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Fertility and sterility     Volume:  42     ISSN:  0015-0282     ISO Abbreviation:  Fertil. Steril.     Publication Date:  1984 Jul 
Date Detail:
Created Date:  1984-07-20     Completed Date:  1984-07-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  52-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cholesterol / blood
Danazol / pharmacology*,  therapeutic use
Endometriosis / blood*,  drug therapy
Female
Humans
Lipoproteins / blood*
Lipoproteins, HDL / blood
Lipoproteins, LDL / blood
Lipoproteins, VLDL / blood
Pelvic Neoplasms / blood*,  drug therapy
Phospholipids / blood
Pregnadienes / pharmacology*
Time Factors
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Lipoproteins; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Phospholipids; 0/Pregnadienes; 0/Triglycerides; 17230-88-5/Danazol; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Experience with diethylstilbestrol-exposed infertile women in a program of in vitro fertilization.
Next Document:  Sperm count results from 861 American chemical/agricultural workers from 14 separate studies.